![]() |
![]() |
![]() |
![]() |
1-EP | Post Transplant Cyclophosphamide as a Cost Effective Innovation to Advance Transplantation in Advanced Hematological Malignancies. | Mohmad Shahnawaz Beg | ![]() |
![]() |
|||
3-EP | Diagnostic utility of Whole genomic sequencing in acute leukaemia | DANUSHKA DISSANAYAKA | ![]() |
![]() |
|||
15-EP | Childhood B-cell lymphoblastic leukemia accompanied by intrachromosomal amplification of chromosome 21:case report and literature review | Jiantuo Liu | ![]() |
![]() |
|||
35-EP | Modifying Cardiovascular risk factors for patients on Tyrosine Kinase Inhibitors: sharing our improved practice | Anna Elliott | ![]() |
![]() |
|||
74-EP | Developing a method evaluating quality-of -life of patients living with monoclonal gammopathy of undefined significance | indra ramasamy | ![]() |
![]() |
|||
78-EP | Hodgkin Lymphoma in Older Patients (HoOP)- A Retrospective Study | Aising Barrett | ![]() |
![]() |
|||
105-EP | Monitoring Cardiovascular Risk Factors for patients on Bruton Tyrosine Kinase Inhibitors sharing improvements in practice. | Anna Elliott | ![]() |
![]() |
|||
110-EP | Genetic Analysis using the R92 Panel of Rare Anaemia and Referral Submission Quality | Jessica Coyle | ![]() |
![]() |
|||
117-EP | Comparing paediatric sickle cell pain protocol adherence with national and trust guidelines in A&E. | Yang Yang Wang | ![]() |
![]() |
|||
157-EP | Assessing Safety of Blood Donations from Smokers: A Comparative Analysis of Biomarkers and Hematological Parameters | Ifeyinwa Okafor | ![]() |
![]() |
|||
164-EP | Patterns and Outcomes of Transfusion-dependant -Thalassemia (TDT) Children Over Five Years in Uttarakhand India | Manish Raturi | ![]() |
![]() |
|||
171-EP | Establishing Venous Thromboembolism Prevention Champions at a District General Hospital | Alexandra Butler | ![]() |
![]() |
|||
179-EP | Single centre experience on direct acting oral anticoagulant levels and clinical outcomes | Richard Hinton | ![]() |
![]() |
|||
220-PP | A Randomised Trial of Intermediate-Dose Heparin versus Standard-Dose Thromboprophylaxis in Critically Ill Patients with COVID-19 | Charlotte Bradbury | ![]() |
![]() |
27-29 April Glasgow
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|